Clostridium (reclassified as “Clostridioides”) difficile infection (CDI) is a healthcare-
associated infection and significant source of potentially preventable morbidity, recurrence …

The gut microbiota plays a critical role in pathogen defense. Studies using antibiotic-treated
mice reveal mechanisms that increase susceptibility to Clostridioides difficile infection (CDI) …

Objectives Clostridioides difficile is an important pathogen of healthcare-associated
gastrointestinal infections. Recently, an increased number of C. difficile infection (CDI) …

We investigated epidemiologic and molecular characteristics of healthcare-associated (HA)
and community-associated (CA) Clostridioides difficile infection (CDI) among adult patients …

Antibiotic exposure is a crucial risk factor for community-acquired Clostridioides difficile
infection (CA-CDI). However, the relative risks associated with specific antibiotics may vary …

The molecular epidemiology and antimicrobial resistance of Clostridioides difficile were
studied in South Korea in 2017 as part of a National Surveillance System. From February to …

Abstract Background Community-onset Clostridium difficile infections (CDI) are increasingly
common, but there is little data on outcomes. The purpose of this study is to describe the …

Clostridioides difficile is the leading cause of nosocomial diarrhea and antibiotics associated
diarrhea, but it is also an increasingly common cause of community diarrhea. In recent years …

Background: Clostridium difficile is the most common causes of hospital-acquired diarrhea
affecting particularly hospitalized patients globally. This organism has re-emerged in recent …

Objectives This study was designed to investigate the molecular epidemiology of
Clostridioides difficile isolates in South Korea and to evaluate risk factors for rifaximin-non …